There are multiple tumor-infiltrating lymphocytes (TILs) and relevant immune checkpoints existing in gastrointestinal stromal tumor (GIST), which provides opportunities and rationales for developing effective immunotherapies. Recent studies have suggested that checkpoint TIM-3/Gal-9 plays a pivotal role on immune response in multiple tumors, similar to the PD-1/PD-L1, emerging as a potential therapeutic target. However, their functions in GIST are unrevealed. Hence, the expression of immune checkpoints TIM-3 and Gal-9, as well as the infiltration of CD8 T cells and NK cells, is described in 299 cases of GIST specimens. The results showed that TIM-3 and Gal-9 are mainly expressed in TILs, rarely in tumor cells. Expression levels of TIM-3 and Gal-9 significantly differ in varying risks of GIST and exert opposite distribution trends. Indicated by prognosis analysis, high TIM-3 expression of TILs was associated with improved outcome, while low expression levels of TIM-3 in combination with low amounts of CD8 and CD56 TILs predict extremely poor survival. The integrated analysis of TIM-3, CD8, and CD56 TILs as one biomarker is a reliable independent predictor of prognosis. In conclusion, low densities of TIM-3 TILs are associated with poor survival, and integrated immune biomarkers lead to superior predictors of GIST prognosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907748PMC
http://dx.doi.org/10.1155/2021/6647292DOI Listing

Publication Analysis

Top Keywords

tim-3 gal-9
12
tim-3
8
tumor-infiltrating lymphocytes
8
gastrointestinal stromal
8
immune checkpoints
8
expression levels
8
levels tim-3
8
tils associated
8
cd8 cd56
8
cd56 tils
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!